Operator: Hello, and welcome to the eGain Corporation Fiscal 2025 Second Quarter Financial Results Call. All participants ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...

At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Syantra, Inc., a precision biotechnology company revolutionizing cancer detection and treatment, proudly announces Dr. Edith A. Perez as chair and Dr. Maria Theodoulou and Dr. Adetunji Toriola as ...

Since this business is outside of HCM's core business of doing R&D, manufacture ... this transaction to further develop its internal pipeline of products to markets. This deal, which is expected ...

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new product ...

In early 2024, Insilico published a Nature Biotechnology paper presenting the entire R&D journey from AI algorithms to Phase II clinical trials of ISM001-055, the company's lead drug pipeline with ...

Interestingly, a Chinese OEM also announced the opening of an R&D centre in Europe today, with Li Auto opening a new facility in Munich, Germany.

Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Cardiovascular Pacing and ICD Leads Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key ...

Strategically focused pipeline optimizes resource allocation to progress two ... 4DMT will focus the majority of its R&D resources and operations on global development and pre-commercial planning for ...